Loading...
Market
Will AlphaProteo be used in a published research study by a top-tier scientific journal by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Research publications in top-tier scientific journals such as Nature, Science, or Cell
Story
Google DeepMind Unveils AlphaProteo with 3-300x Better Protein Design
Sep 5, 2024, 03:53 PM
Google DeepMind has announced AlphaProteo, a new machine learning system designed to create high-affinity protein binders. AlphaProteo achieves binding affinities and success rates that are 3-300 times better compared to existing methods. The system aims to unlock the design of proteins for challenging and impactful biology problems. However, some researchers have expressed disappointment over the lack of methodological details in DeepMind's white paper on AlphaProteo. The white paper indicates that AF3 is better than AF2 for filtering de novo designed binders.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Drug Development • 25%
Disease Diagnosis • 25%
Biosensor Technology • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%
Cancer • 25%
Autoimmune disorders • 25%
Infectious diseases • 25%
Other • 25%
Cancer • 25%
Neurodegenerative Diseases • 25%
Cardiovascular Diseases • 25%
Other • 25%